| |
      
|
|
  
  |
| |
Canadian patients "short changed" |
|
|
Patients in Canada have significantly fewer choices when
it comes to access to innovative medicines compared to patients
in Sweden, Switzerland, France and the UK, says a new international
comparison released today by Canada’s Research-Based
Pharmaceutical Companies (Rx&D). Read
more
Revised: December
7, 2006
|
|
|
|
|